Study to Assess Satisfaction in Patients Treated With Copaxone®
- Study Title
- Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxoneֲ®
- Teva Identifier
- TV44400-CNS-40083 | 2015-000922-12
- ClinicalTrials.gov Identifier
- NCT02499900
- Study Status
- Completed
- Trial Condition(s)
- Multiple Sclerosis
- Interventions
- Drug: Copaxoneֲ®
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- August 10, 2015 - June 2, 2017
- Phase
- Phase 4
